TheraSphere™

Y-90 Glass Microspheres

20 Years of Success in HCC Treatment

TheraSphere™ Y-90 Glass Microspheres are a proven, evidence-based HCC therapy that hits tumors hard. Now you have the power to reliably shrink and destroy tumors and enhance outcomes.

The TARGET Study

The TARGET Study is a global, real-world data set across 8 countries demonstrating the reproducibility of treatment with TheraSphere Y-90 glass microspheres, confirmed by Simplicit⁹⁰Y^TM Personalized Dosimetry Software.

Learn More

The LEGACY Study

Learn how the LEGACY study confirms TheraSphere as a neoadjuvant or standalone therapy in treating HCC.

Learn More

*Refers to HCC or associated tumors

Top